| 0 |
HARVEY-BRADSHAW INDEX ABNORMAL |
2 |
0.0690 |
| 1 |
GLAUCOMATOCYCLITIC CRISES |
1 |
0.0435 |
| 2 |
EYELID DISCOLOURATION |
1 |
0.0196 |
| 3 |
PLAGUE |
1 |
0.0149 |
| 4 |
FAECAL CALPROTECTIN DECREASED |
1 |
0.0128 |
| 5 |
PSEUDOPOLYPOSIS |
1 |
0.0069 |
| 6 |
FAECAL CALPROTECTIN ABNORMAL |
2 |
0.0048 |
| 7 |
OPHTHALMIC VEIN THROMBOSIS |
1 |
0.0041 |
| 8 |
CAVERNOUS SINUS THROMBOSIS |
1 |
0.0039 |
| 9 |
SARCOID-LIKE REACTION |
1 |
0.0039 |
| 10 |
METASTASES TO BLADDER |
1 |
0.0035 |
| 11 |
COLON DYSPLASIA |
1 |
0.0035 |
| 12 |
ILEOCAECAL RESECTION |
1 |
0.0029 |
| 13 |
WOUND NECROSIS |
1 |
0.0021 |
| 14 |
ACUTE INTERSTITIAL PNEUMONITIS |
1 |
0.0019 |
| 15 |
TERMINAL ILEITIS |
1 |
0.0016 |
| 16 |
PERFORATED ULCER |
1 |
0.0013 |
| 17 |
FOETAL DISORDER |
1 |
0.0012 |
| 18 |
COLONIC ABSCESS |
1 |
0.0012 |
| 19 |
INTRACRANIAL MASS |
1 |
0.0011 |
| 20 |
BLOOD IRON ABNORMAL |
1 |
0.0010 |
| 21 |
TONSILLAR DISORDER |
1 |
0.0009 |
| 22 |
GASTROINTESTINAL BACTERIAL INFECTION |
1 |
0.0009 |
| 23 |
INFECTED CYST |
1 |
0.0008 |
| 24 |
OBSTRUCTION |
3 |
0.0008 |
| 25 |
PERIPHERAL ARTERY THROMBOSIS |
1 |
0.0007 |
| 26 |
LOSS OF THERAPEUTIC RESPONSE |
2 |
0.0006 |
| 27 |
MUCOUS STOOLS |
3 |
0.0006 |
| 28 |
ILEAL STENOSIS |
1 |
0.0006 |
| 29 |
INTESTINAL STENOSIS |
2 |
0.0005 |
| 30 |
RENAL NEOPLASM |
1 |
0.0005 |
| 31 |
COLITIS ULCERATIVE |
21 |
0.0005 |
| 32 |
PARESIS |
1 |
0.0004 |
| 33 |
WEIGHT ABNORMAL |
1 |
0.0004 |
| 34 |
GASTROINTESTINAL OBSTRUCTION |
1 |
0.0004 |
| 35 |
ANAL ABSCESS |
2 |
0.0004 |
| 36 |
LARGE INTESTINAL ULCER |
1 |
0.0004 |
| 37 |
ORAL FUNGAL INFECTION |
1 |
0.0004 |
| 38 |
THERAPY PARTIAL RESPONDER |
5 |
0.0003 |
| 39 |
BLOOD BLISTER |
1 |
0.0003 |
| 40 |
PNEUMONIA VIRAL |
1 |
0.0003 |
| 41 |
INCORRECT DISPOSAL OF PRODUCT |
1 |
0.0003 |
| 42 |
PROSTATE CANCER METASTATIC |
1 |
0.0003 |
| 43 |
HEPATIC FIBROSIS |
1 |
0.0003 |
| 44 |
DERMATITIS EXFOLIATIVE GENERALISED |
1 |
0.0003 |
| 45 |
DEFAECATION URGENCY |
2 |
0.0003 |
| 46 |
RENAL TRANSPLANT |
1 |
0.0003 |
| 47 |
CHEMOTHERAPY |
1 |
0.0003 |
| 48 |
GALLBLADDER OPERATION |
1 |
0.0002 |
| 49 |
VITAMIN B12 DEFICIENCY |
1 |
0.0002 |
| 50 |
DEMYELINATION |
1 |
0.0002 |
| 51 |
INTERVERTEBRAL DISC DISORDER |
1 |
0.0002 |
| 52 |
BONE CANCER |
1 |
0.0002 |
| 53 |
MENINGITIS ASEPTIC |
1 |
0.0002 |
| 54 |
IRON DEFICIENCY |
1 |
0.0002 |
| 55 |
FREQUENT BOWEL MOVEMENTS |
6 |
0.0002 |
| 56 |
ABDOMINAL HERNIA |
1 |
0.0002 |
| 57 |
OVARIAN CANCER |
2 |
0.0002 |
| 58 |
UMBILICAL HERNIA |
1 |
0.0002 |
| 59 |
AFFECT LABILITY |
2 |
0.0002 |
| 60 |
THERAPY CHANGE |
2 |
0.0002 |
| 61 |
ABDOMINAL TENDERNESS |
1 |
0.0002 |
| 62 |
FEMORAL NECK FRACTURE |
1 |
0.0002 |
| 63 |
NONSPECIFIC REACTION |
1 |
0.0002 |
| 64 |
HEPATIC STEATOSIS |
3 |
0.0002 |
| 65 |
PRODUCT PREPARATION ISSUE |
1 |
0.0002 |
| 66 |
POSTOPERATIVE WOUND INFECTION |
1 |
0.0001 |
| 67 |
RESPIRATION ABNORMAL |
1 |
0.0001 |
| 68 |
AUTOIMMUNE HEPATITIS |
1 |
0.0001 |
| 69 |
PAPULE |
1 |
0.0001 |
| 70 |
UTERINE LEIOMYOMA |
1 |
0.0001 |
| 71 |
COLON CANCER |
2 |
0.0001 |
| 72 |
TENDON PAIN |
1 |
0.0001 |
| 73 |
INSURANCE ISSUE |
2 |
0.0001 |
| 74 |
GASTROINTESTINAL INFLAMMATION |
1 |
0.0001 |
| 75 |
BRAIN FOG |
2 |
0.0001 |
| 76 |
ELECTROCARDIOGRAM ABNORMAL |
1 |
0.0001 |
| 77 |
HAEMATOCHEZIA |
7 |
0.0001 |
| 78 |
POST PROCEDURAL INFECTION |
1 |
0.0001 |
| 79 |
FACIAL PARALYSIS |
1 |
0.0001 |
| 80 |
SKIN HYPERPIGMENTATION |
1 |
0.0001 |
| 81 |
GROIN PAIN |
1 |
0.0001 |
| 82 |
PRODUCT COMMUNICATION ISSUE |
1 |
0.0001 |
| 83 |
MYOSITIS |
1 |
0.0001 |
| 84 |
ANAL INCONTINENCE |
1 |
0.0001 |
| 85 |
HIDRADENITIS |
1 |
0.0001 |
| 86 |
BRAIN NEOPLASM |
1 |
0.0001 |
| 87 |
RETINAL DETACHMENT |
1 |
0.0001 |
| 88 |
DIARRHOEA HAEMORRHAGIC |
1 |
0.0001 |
| 89 |
SQUAMOUS CELL CARCINOMA |
1 |
0.0001 |
| 90 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
19 |
0.0001 |
| 91 |
INTENTIONAL DOSE OMISSION |
3 |
0.0001 |
| 92 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
1 |
0.0001 |
| 93 |
INFLAMMATORY BOWEL DISEASE |
1 |
0.0001 |
| 94 |
HYPOTHERMIA |
1 |
0.0001 |
| 95 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 96 |
INJECTION SITE DISCOMFORT |
1 |
0.0001 |
| 97 |
INCONTINENCE |
1 |
0.0001 |
| 98 |
BIPOLAR DISORDER |
1 |
0.0001 |
| 99 |
CLOSTRIDIUM DIFFICILE INFECTION |
2 |
0.0001 |
| 100 |
THERAPEUTIC RESPONSE SHORTENED |
3 |
0.0001 |
| 101 |
COVID-19 PNEUMONIA |
1 |
0.0001 |
| 102 |
THERAPY INTERRUPTED |
6 |
0.0001 |
| 103 |
WRIST FRACTURE |
1 |
0.0001 |
| 104 |
SMALL INTESTINAL OBSTRUCTION |
1 |
0.0001 |
| 105 |
SECRETION DISCHARGE |
1 |
0.0001 |
| 106 |
INTESTINAL OBSTRUCTION |
3 |
0.0001 |
| 107 |
COLITIS |
3 |
0.0001 |
| 108 |
INJECTION SITE INDURATION |
1 |
0.0001 |
| 109 |
PSORIASIS |
10 |
0.0001 |
| 110 |
ANKYLOSING SPONDYLITIS |
1 |
0.0001 |
| 111 |
ADVERSE REACTION |
1 |
0.0001 |
| 112 |
MALIGNANT MELANOMA |
1 |
0.0001 |
| 113 |
PSORIATIC ARTHROPATHY |
3 |
0.0001 |
| 114 |
MASS |
1 |
0.0001 |
| 115 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 116 |
PULMONARY MASS |
1 |
0.0001 |
| 117 |
LYMPHOMA |
1 |
0.0001 |
| 118 |
BASAL CELL CARCINOMA |
1 |
0.0001 |
| 119 |
METASTASES TO BONE |
1 |
0.0001 |
| 120 |
DEVICE USE ERROR |
2 |
0.0001 |
| 121 |
THIRST |
1 |
0.0001 |
| 122 |
GOUT |
1 |
0.0001 |
| 123 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 124 |
ARTHROPATHY |
3 |
0.0001 |
| 125 |
FRACTURE |
1 |
0.0001 |
| 126 |
SEROTONIN SYNDROME |
1 |
0.0001 |
| 127 |
HERNIA |
1 |
0.0001 |
| 128 |
ORAL HERPES |
1 |
0.0001 |
| 129 |
SURGERY |
3 |
0.0001 |
| 130 |
SINUS DISORDER |
1 |
0.0001 |
| 131 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 132 |
ABORTION SPONTANEOUS |
2 |
0.0000 |
| 133 |
TASTE DISORDER |
1 |
0.0000 |
| 134 |
LUNG NEOPLASM MALIGNANT |
2 |
0.0000 |
| 135 |
RIB FRACTURE |
1 |
0.0000 |
| 136 |
DERMATITIS |
1 |
0.0000 |
| 137 |
KNEE ARTHROPLASTY |
1 |
0.0000 |
| 138 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 139 |
FAECES DISCOLOURED |
1 |
0.0000 |
| 140 |
DEVICE DIFFICULT TO USE |
3 |
0.0000 |
| 141 |
MULTIPLE SCLEROSIS |
2 |
0.0000 |
| 142 |
NEURALGIA |
1 |
0.0000 |
| 143 |
HOT FLUSH |
3 |
0.0000 |
| 144 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 145 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 146 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 147 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
1 |
0.0000 |
| 148 |
ARTHRITIS |
3 |
0.0000 |
| 149 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 150 |
LIMB INJURY |
1 |
0.0000 |
| 151 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 152 |
DIVERTICULITIS |
1 |
0.0000 |
| 153 |
ANGINA PECTORIS |
1 |
0.0000 |
| 154 |
ILL-DEFINED DISORDER |
2 |
0.0000 |
| 155 |
CYSTITIS |
1 |
0.0000 |
| 156 |
LOSS OF CONSCIOUSNESS |
4 |
0.0000 |
| 157 |
NIGHT SWEATS |
1 |
0.0000 |
| 158 |
CHOLELITHIASIS |
1 |
0.0000 |
| 159 |
IMPAIRED HEALING |
1 |
0.0000 |
| 160 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 161 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 162 |
OFF LABEL USE |
25 |
0.0000 |
| 163 |
PALPITATIONS |
3 |
0.0000 |
| 164 |
DRUG DOSE OMISSION BY DEVICE |
2 |
0.0000 |
| 165 |
OSTEOPOROSIS |
1 |
0.0000 |
| 166 |
POLLAKIURIA |
1 |
0.0000 |
| 167 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 168 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 169 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 170 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 171 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 172 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 173 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 174 |
DIARRHOEA |
14 |
0.0000 |
| 175 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 176 |
HYPERSENSITIVITY |
4 |
0.0000 |
| 177 |
ABDOMINAL PAIN |
5 |
0.0000 |
| 178 |
PULMONARY EMBOLISM |
2 |
0.0000 |
| 179 |
RENAL CANCER |
1 |
0.0000 |
| 180 |
MIGRAINE |
2 |
0.0000 |
| 181 |
SYNCOPE |
2 |
0.0000 |
| 182 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 183 |
HOSPITALISATION |
3 |
0.0000 |
| 184 |
ILLNESS |
2 |
0.0000 |
| 185 |
ACCIDENTAL EXPOSURE TO PRODUCT |
2 |
0.0000 |
| 186 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 187 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 188 |
SEPSIS |
2 |
0.0000 |
| 189 |
URINARY TRACT INFECTION |
3 |
0.0000 |
| 190 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 191 |
MYOCARDIAL INFARCTION |
3 |
0.0000 |
| 192 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 193 |
CONDITION AGGRAVATED |
5 |
0.0000 |
| 194 |
VERTIGO |
1 |
0.0000 |
| 195 |
DISCOMFORT |
1 |
0.0000 |
| 196 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 197 |
NASOPHARYNGITIS |
3 |
0.0000 |
| 198 |
CHEST PAIN |
3 |
0.0000 |
| 199 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 200 |
ABDOMINAL PAIN UPPER |
3 |
0.0000 |
| 201 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 202 |
SLEEP DISORDER |
1 |
0.0000 |
| 203 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 204 |
MOBILITY DECREASED |
1 |
0.0000 |
| 205 |
UNDERDOSE |
1 |
0.0000 |
| 206 |
PRODUCT DOSE OMISSION ISSUE |
4 |
0.0000 |
| 207 |
EPISTAXIS |
1 |
0.0000 |
| 208 |
HYPOAESTHESIA |
2 |
0.0000 |
| 209 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 210 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 211 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 212 |
CARDIAC FAILURE |
1 |
0.0000 |
| 213 |
PROSTATE CANCER |
1 |
0.0000 |
| 214 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 215 |
FOETAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 216 |
TREATMENT FAILURE |
1 |
0.0000 |
| 217 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 218 |
MYALGIA |
2 |
0.0000 |
| 219 |
FATIGUE |
9 |
0.0000 |
| 220 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 221 |
DRUG INEFFECTIVE |
15 |
0.0000 |
| 222 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 223 |
HEADACHE |
7 |
0.0000 |
| 224 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 225 |
ANXIETY |
3 |
0.0000 |
| 226 |
DYSPHAGIA |
1 |
0.0000 |
| 227 |
CONTUSION |
1 |
0.0000 |
| 228 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 229 |
INJECTION SITE PAIN |
3 |
0.0000 |
| 230 |
ERYTHEMA |
2 |
0.0000 |
| 231 |
ARTHRALGIA |
4 |
0.0000 |
| 232 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 233 |
HAEMORRHAGE |
1 |
0.0000 |
| 234 |
HYPERTENSION |
2 |
0.0000 |
| 235 |
DEATH |
8 |
0.0000 |
| 236 |
MALAISE |
4 |
0.0000 |
| 237 |
FALL |
3 |
0.0000 |
| 238 |
INFLUENZA |
1 |
0.0000 |
| 239 |
DECREASED APPETITE |
2 |
0.0000 |
| 240 |
BACK PAIN |
2 |
0.0000 |
| 241 |
CHILLS |
1 |
0.0000 |
| 242 |
VOMITING |
4 |
0.0000 |
| 243 |
FEELING ABNORMAL |
2 |
0.0000 |
| 244 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 245 |
ASTHENIA |
3 |
0.0000 |
| 246 |
HYPERHIDROSIS |
1 |
0.0000 |
| 247 |
NAUSEA |
6 |
0.0000 |
| 248 |
WEIGHT DECREASED |
2 |
0.0000 |
| 249 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 250 |
TREMOR |
1 |
0.0000 |
| 251 |
URTICARIA |
1 |
0.0000 |
| 252 |
PYREXIA |
2 |
0.0000 |
| 253 |
COVID-19 |
1 |
0.0000 |
| 254 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 255 |
HYPOTENSION |
1 |
0.0000 |
| 256 |
CONSTIPATION |
1 |
0.0000 |
| 257 |
WEIGHT INCREASED |
1 |
0.0000 |
| 258 |
DEPRESSION |
1 |
0.0000 |
| 259 |
INSOMNIA |
1 |
0.0000 |
| 260 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 261 |
PAIN |
2 |
0.0000 |
| 262 |
PRURITUS |
1 |
0.0000 |
| 263 |
DYSPNOEA |
1 |
0.0000 |